The translocator protein (TSPO) as a novel target for the treatment of Alzheimers disease [ 2010 - 2012 ]

Also known as: Novel treatment approach for Alzheimers disease

Research Grant

[Cite as]

Researchers: Prof Lars Ittner (Principal investigator) ,  Prof Michael Kassiou

Brief description Alzheimer's disease (AD) is the most prevalent dementia, characterized by progressive loss of memory. An estimated 230,000 Australians currently suffer from AD, causing a huge impact on their families and carers, as well as on national finances. The present therapies are very limited, and there is no cure. Thus, there is a need for novel treatment strategies. We have developed novel drugs that represent an innovative approach to the treatment of AD.

Funding Amount $AUD 629,260.47

Funding Scheme NHMRC Project Grants

Notes Standard Project Grant

Click to explore relationships graph
Viewed: [[ro.stat.viewed]]